200 likes | 340 Views
PMTCT overview: current-scale up efforts and challenges in operations and implementation. Dr Angela Mushavi National PMTCT and Pediatric HIV Care and Treatment Coordinator: Zim IAS 2011, Rome: Italy 17/07/2011. Outline of Presentation. Background and epidemiology of HIV in Zimbabwe
E N D
PMTCT overview: current-scale up efforts and challenges in operations and implementation Dr Angela Mushavi National PMTCT and Pediatric HIV Care and Treatment Coordinator: Zim IAS 2011, Rome: Italy 17/07/2011
Outline of Presentation • Background and epidemiology of HIV in Zimbabwe • PMTCT Program performance in 2010 • Current scale-up efforts and challenges with implementation • And so wither Zimbabwe?
Background of Zimbabwe Population: ~12 million Adult HIV prevalence: 13.7% ANC sero-prevalence : 16.1% An estimated 1,1 mil Zimbabweans are HIV positive* Of these, 151, 749 are children 0-14 years* New pediatric HIV infections are estimated at 14,976* (90% from MTCT) 1,090 patients dying weekly due to AIDS Source: DHS 2005/6 & MOHCW HIV estimates 2009*
Background of Zimbabwe • 94% of pregnant women received ANC (ZDHS 05/06) • 68% of pregnant women delivered in Health Institutions (ZDHS 05/06) • MNCH indices of Zimbabwe • 398,889 expected pregnancies in 2010; of these, 47,494 are to HIV infected pregnant women • In the last 10 years, MMR has increased • 555/1000,000: ZDHS 2005/6 • 725/100,000: MOHCW 2007 Maternal and Perinatal Mortality Study • HIV/AIDS is leading contributor to high MMR (26%) • 21% of the Under 5 Mortality Rate (<5MR) is attributed to HIV/AIDS (MIMS 2009)
National PMTCT Program • PMTCT started as a 3 site pilot in 1999 • PMTCT program rolled-out in 2002 • Initially using only SD NVP for both the HIV infected mothers and their HIV exposed infants • Piloted the use of more efficacious regimens (MER) as per 2006 WHO Guidelines in 2007 • Roll-out of MER only started in 2009 • Zimbabwe has officially adopted the 2010 WHO guidelines (Option A) and roll-out is in progress
Current geographic coverage of PMTCT • Total # of health facilities: 1643 • Total # of ANC providing PMTCT: 1560 (95%) • Comprehensive PMTCT 1200 (77%) (Both on site HIV testing & ARV prophylaxis) • Minimum PMTCT sites 360 (No on-site HIV testing but have ARV prophylaxis) • 883 sites (57%) of all ANC sites in the 62 districts offer MER while 366 sites (23%) collect DBS for HIV DNA PCR (EID)
PMTCT: Achievements • Strong PMTCT partnership forum (PPF) that supports scale-up • Transitioning to more efficacious regimens for PMTCT (moving to Option A) • Revised IMAI/IMPAC curriculum with on-going training and support supervision of staff • HIV DNA PCR for early infant diagnosis of HIV (EID) available since 2007 • Support from government, donors and partners to provide resources for PMTCT scale-up; including GFATM and the National AIDS Trust Fund (AIDS levy)
Achievements of the PMTCT program • Elimination campaign officially launched in January of 2011 • Strengthened efforts towards SRH/HIV integration targeting Prongs 1 and 2 • Receiving increasing funding commitments from MOHCW through NAC, GFATM, EGPAF and other donors to scale-up towards elimination of new Pediatric HIV infections • Deploying Point of Care CD4 machines
Point of Care (POC) CD4 machines • MOHCW has given official go-ahead to procure and deploy these devices • Roll out and evaluation of the machines under field conditions on-going • Evaluation of Point of Care CD4 machines: end 2009-2010 • No significant difference between POC and laboratory based CD4 machines • Nurses able to operate as well as lab scientists
PMTCT: Challenges Some progress yes; but much more needed to increase quality and coverage towards universal access. In fact, much more needed to attain elimination of Pediatric HIV by 2015 Community mobilization and demand generation: some effort but how much is enough? Stigma and discrimination? Low male participation Late booking, user fees and home deliveries: a missed opportunity for PMTCT Lack of tracking of mother-infant pairs in PMTCT; and slow scale-up of EID and early treatment of HIV positive infants M&E; including revision of tools and data quality and issues
PMTCT: Challenges • Challenge with human resources for health (HRH): • High staff attrition rates; with constant need to train and retrain (IMAI/IMPAC) • No official task sharing policies/strategies • Few health care workers trained in the revised 2010 WHO guidelines for: • Infant feeding in the context of HIV • PMTCT • Antiretroviral treatment
Challenges: PMTCT • Procurement, supply chain management for PMTCT in the face of an under-resourced health care system • Inadequate resources for ARVs, EID and other lab support(e.g. HR, CD4 machines and consumables) • Shortages of other commodities: Cotrimoxazole, HIV Test kits and essential equipment for the delivery of quality and comprehensive ANC and MCH services • Minimal integration of PMTCT within the broader sexual and reproductive & maternal newborn and child health agenda: critical to helping us attain MDGs 4, 5 and 6 by 2015
And so do we give up? • A most emphatic no! • Understanding these challenges allows us to design innovative and creative solutions • And with support from government, multilateral and bilateral agencies including PEPFAR, GFATM, and others, we will truly reach the goal of elimination of new HIV infections in children by 2015